About Pi Industries Limited
Data last updated: 29 April 2026
Pi Industries Limited is a public limited company based in Udaipur, Rajasthan, India. It specialises in crop protection, a part of the broader agriculture sector. Incorporated on 31 December 1946, the company has been in operation for over 80 years.
Registered with ROC Jaipur under CIN L24211RJ1946PLC000469. Listed on BSE: 523642 and NSE: PIIND.
Capital: an authorised share capital of ₹88.8 Cr and a paid-up capital of ₹15.17 Cr. Formerly known as Mewar Oil and General Mills Limited and Pesticides India Ltd. It is led by directors including Vegulaparanan Kasi Viswanathan and Narayan Keelveedhi Seshadri.
Last AGM: 14 August 2025. Financial statements filed for year ended 31 March 2025. Office: Udaisagar Road, Udaipur, Rajasthan, India – 313001.
As per the financials filed for FY 2025, the company reported a revenue of ₹8,322 Cr, a growth of 6% compared to the previous year.
The company has a workforce of approximately 3,499 employees as per the latest available data. Its group structure includes 5 subsidiaries and 1 joint venture.
The company is associated with 2 brands - Pi Health Sciences, Pi Industries. As per MCA filings, the company has open charges of ₹840.24 Cr and satisfied charges of ₹1,299.47 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website piindustries.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressUdaisagar Road, Udaipur, Rajasthan, India – 313001
-
IndustryAgriculture, Crop Protection
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Pi Industries Limited
Pi Industries Limited has undergone 2 name changes throughout its history. The company was previously known as Mewar Oil And General Mills Limited, and Pesticides India Ltd. The current legal name is Pi Industries Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Pi Industries Limited | Current |
| Mewar Oil And General Mills Limited | Previous |
| Pesticides India Ltd | Previous |
Associated Brands with Pi Industries Limited
Pi Industries Limited operates two associated brands: PI Health Sciences and PI Industries. These brands represent Pi Industries Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Specializes in CRO and CDMO services for medicinal chemistry and API manufacturing. | pihealthsciences.com | |
| Agro chemicals are manufactured along with custom synthesis services. | piindustries.com |
Competitors & Alternatives of Pi Industries Limited
Brands and companies operating in the same space as Pi Industries Limited include Pharmaron, Pfizer, Lonza and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Drug discovery and development services for small molecules are provided. | Beijing, China, China | 2003 |
|
|
Pharmaceutical products for treating multiple diseases are provided. | New York, United States, United States | 1849 |
|
|
CDMO services for pharma, biotech, and specialty ingredients are provided. | Basel, Switzerland, Switzerland | 1897 |
|
|
AI powered scientific data management and workflow automation solutions | - | 2005 |
|
|
Generic drugs and clinical research services are provided globally. | - | 1885 |
|
|
Major auto components are manufactured and supplied by Aequs. | Belgaum, India, India | 2006 |
|
|
Actives, advanced intermediates, and specialty chemicals are custom manufactured. | Mumbai, India, India | 2005 |
|
|
Laboratory testing, clinical trial research, and biopharma services are provided. | Johnson City, United States, United States | 2002 |
|
|
Contract manufacturer of chemical, automotive, aircraft, and other products | Los Angeles, United States, United States | 1939 |
|
|
Developer of therapeutics for oncology and dermatology | Panchkula, India, India | 2005 |
Business Activity of Pi Industries Limited
Pi Industries Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Pi Industries Limited
Pi Industries Limited is audited by Price waterhouse chartered Accountants LLP (ICAI peer reviewed, certificate valid till 2026-11-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Price waterhouse chartered Accountants LLP (ICAI peer reviewed, certificate valid till 2026-11-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Pi Industries Limited
Pi Industries Limited is currently managed by 12 directors, with 40 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vegulaparanan Kasi Viswanathan | Director | 19 May 2025 | 1 Years 1 Months | Current |
|
Narayan Keelveedhi Seshadri
Also directs:
Sbi Life Insurance Company Limited, Tranzmute Business Advisory Llp, Lindner Properties Limited Liability Partnership and 5 more
|
Director | 27 Jan 2006 | 20 Years 5 Months | Current |
|
Pia Singh
Also directs:
Beverly Builders Llp, Excel Housing Construction Llp, Mallika Housing Company Llp and 5 more
|
Director | 03 Aug 2022 | 3 Years 11 Months | Current |
|
Shobinder Duggal
Also directs:
Sanofi Consumer Healthcare India Limited, Kirloskar Brothers Limited, Abb India Limited and 1 more
|
Director | 12 Nov 2021 | 4 Years 7 Months | Current |
|
Tanjore Balganesh Soundararajan
Also directs:
Pi Health Sciences Limited, Gangagen Biotechnologies Private Limited, Byonox Private Limited and 3 more
|
Director | 16 May 2017 | 9 Years 1 Months | Current |
| Rafael Julio Del Rio Donoso | Director | 09 Feb 2024 | 2 Years 4 Months | Current |
Financials of Pi Industries Limited FY 2026 filings available
Pi Industries Limited reported revenue of ₹6,713.7 Cr (down 15.85% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹6,713.7 Cr | ₹7,977.8 Cr | ₹7,665.8 Cr | ₹6,492 Cr | ₹5,299.5 Cr | ₹4,577 Cr | ₹3,366.5 Cr |
| Other Income | ₹310.7 Cr | ₹344.2 Cr | ₹207.7 Cr | ₹159 Cr | ₹101.4 Cr | ₹124.9 Cr | ₹48.9 Cr |
| Total Income | ₹7,024.4 Cr | ₹8,322 Cr | ₹7,873.5 Cr | ₹6,651 Cr | ₹5,400.9 Cr | ₹4,701.9 Cr | ₹3,415.4 Cr |
| Cost of Materials Consumed | ₹2,990 Cr | ₹3,324.8 Cr | ₹3,578.7 Cr | ₹3,434.3 Cr | ₹2,950.8 Cr | ₹2,508.1 Cr | ₹1,687.7 Cr |
| Purchases of Stock-in-Trade | ₹168 Cr | ₹177.9 Cr | ₹262.9 Cr | ₹188.1 Cr | ₹173.9 Cr | ₹163.7 Cr | ₹161.9 Cr |
| Changes in Inventories | -₹324.7 Cr | ₹268.4 Cr | -₹4 Cr | -₹69.7 Cr | -₹201.9 Cr | -₹100.6 Cr | -₹2.2 Cr |
| Employee Benefit Expense | ₹907.7 Cr | ₹783.7 Cr | ₹701.3 Cr | ₹526.6 Cr | ₹480.4 Cr | ₹416.9 Cr | ₹320.9 Cr |
| Finance Costs | ₹16.4 Cr | ₹33 Cr | ₹30 Cr | ₹37.1 Cr | ₹12.8 Cr | ₹28.2 Cr | ₹17 Cr |
| Depreciation & Amortisation | ₹406.6 Cr | ₹352.5 Cr | ₹308.2 Cr | ₹226.5 Cr | ₹201.8 Cr | ₹174.8 Cr | ₹136.7 Cr |
| Other Expenses | ₹1,273.1 Cr | ₹1,244 Cr | ₹1,112.2 Cr | ₹870.6 Cr | ₹753.9 Cr | ₹576.7 Cr | ₹480.4 Cr |
| Total Expenses | ₹5,437.1 Cr | ₹6,184.3 Cr | ₹5,989.3 Cr | ₹5,213.5 Cr | ₹4,371.7 Cr | ₹3,767.8 Cr | ₹2,802.4 Cr |
| Profit Before Exceptional Items & Tax | ₹1,587.3 Cr | ₹2,137.7 Cr | ₹1,884.2 Cr | ₹1,437.5 Cr | ₹1,029.2 Cr | ₹934.1 Cr | ₹613 Cr |
| Exceptional Items | ₹103.1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹1,690.4 Cr | ₹2,137.7 Cr | ₹1,884.2 Cr | ₹1,437.5 Cr | ₹1,029.2 Cr | ₹934.1 Cr | ₹613 Cr |
| Total Tax Expense | ₹375.3 Cr | ₹481.8 Cr | ₹213.2 Cr | ₹214.8 Cr | ₹189 Cr | ₹200.2 Cr | ₹157.2 Cr |
| Net Profit | ₹1,320.8 Cr | ₹1,660.2 Cr | ₹1,681.5 Cr | ₹1,229.5 Cr | ₹843.8 Cr | ₹738.3 Cr | ₹456.6 Cr |
| attributable to Owners | ₹1,300.4 Cr | ₹1,649.7 Cr | ₹1,681.5 Cr | ₹1,229.5 Cr | ₹0 | ₹808.1 Cr | ₹401 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹20.4 Cr | -₹10.5 Cr | ₹24.5 Cr | -₹38.4 Cr | ₹8.2 Cr | ₹69.8 Cr | -₹55.6 Cr |
| Total Comprehensive Income | ₹1,300.4 Cr | ₹1,649.7 Cr | ₹1,706 Cr | ₹1,191.1 Cr | ₹852 Cr | ₹808.1 Cr | ₹401 Cr |
| EBITDA (computed) | ₹2,010.3 Cr | ₹2,523.2 Cr | ₹2,222.4 Cr | ₹1,701.1 Cr | ₹1,243.8 Cr | ₹1,137.1 Cr | ₹766.7 Cr |
| Basic EPS | ₹87.06 | ₹109.44 | ₹110.85 | ₹81.06 | ₹55.65 | ₹49.92 | ₹33.08 |
| Diluted EPS | ₹87.06 | ₹109.42 | ₹110.83 | ₹81.04 | ₹55.63 | ₹49.89 | ₹33.08 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹13,444 Cr | ₹12,277 Cr | ₹10,764 Cr | ₹8,479.7 Cr |
| Non-current Assets | ₹5,949 Cr | ₹5,324.5 Cr | ₹4,085.5 Cr | ₹2,817.4 Cr |
| Current Assets | ₹7,494.7 Cr | ₹6,952.2 Cr | ₹6,678.5 Cr | ₹5,662.3 Cr |
| Property, Plant & Equipment | ₹3,678.3 Cr | ₹3,318.3 Cr | ₹2,954.3 Cr | ₹2,494.4 Cr |
| Inventories | ₹1,216.7 Cr | ₹983.9 Cr | ₹1,301.2 Cr | ₹1,397.6 Cr |
| Trade Receivables | ₹2,319.9 Cr | ₹1,832.6 Cr | ₹1,091.1 Cr | ₹838.1 Cr |
| Cash & Equivalents | ₹283.3 Cr | ₹592.3 Cr | ₹886.5 Cr | ₹872.7 Cr |
| Equity (Net Worth) | ₹11,231 Cr | ₹10,157 Cr | ₹8,731 Cr | ₹7,198.5 Cr |
| Equity Share Capital | ₹15.2 Cr | ₹15.2 Cr | ₹15.2 Cr | ₹15.2 Cr |
| Borrowings (Non-current) | ₹149 Cr | ₹78 Cr | ₹61.7 Cr | ₹0 |
| Borrowings (Current) | ₹89.3 Cr | ₹33.7 Cr | ₹66.2 Cr | ₹0 |
| Total Debt (computed) | ₹238.3 Cr | ₹111.7 Cr | ₹127.9 Cr | ₹0 |
| Current Liabilities | ₹1,776.7 Cr | ₹1,727.7 Cr | ₹1,710.6 Cr | ₹1,181.8 Cr |
| Total Liabilities | ₹2,213.2 Cr | ₹2,119.7 Cr | ₹2,033 Cr | ₹1,281.2 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹474 Cr | ₹1,413 Cr | ₹2,035.9 Cr | ₹1,501.4 Cr | ₹528.7 Cr |
| Investing Cash Flow | -₹613.5 Cr | -₹1,424.2 Cr | -₹1,800.5 Cr | -₹496.2 Cr | -₹110.4 Cr |
| Financing Cash Flow | -₹171 Cr | -₹286.5 Cr | -₹221.6 Cr | -₹483.1 Cr | -₹177.3 Cr |
| Capital Expenditure | ₹1,117.8 Cr | ₹850 Cr | ₹620.4 Cr | ₹326.3 Cr | ₹337.1 Cr |
| Free Cash Flow (computed) | -₹643.8 Cr | ₹563 Cr | ₹1,415.5 Cr | ₹1,175.1 Cr | ₹191.6 Cr |
| Dividends Paid | ₹227.8 Cr | ₹227.6 Cr | ₹174.4 Cr | ₹113.7 Cr | ₹75.8 Cr |
| Net Change in Cash | -₹309 Cr | -₹294.2 Cr | ₹13.8 Cr | ₹522.1 Cr | ₹241 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,565.2 Cr | ₹1,375.7 Cr | ₹1,872.3 Cr | ₹1,900.5 Cr | ₹1,787.1 Cr | ₹1,900.8 Cr | ₹2,221 Cr | ₹2,068.9 Cr | ₹1,741 Cr | ₹1,897.5 Cr | ₹2,116.9 Cr | ₹1,910.4 Cr |
| Other Income | ₹75.6 Cr | ₹66.7 Cr | ₹82.5 Cr | ₹85.9 Cr | ₹73.4 Cr | ₹75.9 Cr | ₹122.2 Cr | ₹72.7 Cr | ₹57.9 Cr | ₹56.1 Cr | ₹46.9 Cr | ₹46.9 Cr |
| Total Income | ₹1,640.8 Cr | ₹1,442.4 Cr | ₹1,954.8 Cr | ₹1,986.4 Cr | ₹1,860.5 Cr | ₹1,976.7 Cr | ₹2,343.2 Cr | ₹2,141.6 Cr | ₹1,798.9 Cr | ₹1,953.6 Cr | ₹2,163.8 Cr | ₹1,957.3 Cr |
| Cost of Materials Consumed | ₹669 Cr | ₹671.6 Cr | ₹892 Cr | ₹757.4 Cr | ₹773.3 Cr | ₹787.4 Cr | ₹915.8 Cr | ₹848.3 Cr | ₹849.7 Cr | ₹779.9 Cr | ₹977.2 Cr | ₹971.9 Cr |
| Purchases of Stock-in-Trade | ₹16.1 Cr | ₹36.2 Cr | ₹81.9 Cr | ₹33.8 Cr | ₹24.9 Cr | ₹43.7 Cr | ₹81.1 Cr | ₹28.2 Cr | ₹38.1 Cr | ₹42.4 Cr | ₹114.7 Cr | ₹67.7 Cr |
| Changes in Inventories | -₹25.2 Cr | -₹143.9 Cr | -₹173.5 Cr | ₹17.9 Cr | ₹4.8 Cr | ₹67.9 Cr | ₹74.5 Cr | ₹121.2 Cr | -₹84.4 Cr | ₹59 Cr | ₹39.2 Cr | -₹17.8 Cr |
| Employee Benefit Expense | ₹226.8 Cr | ₹228.1 Cr | ₹220.5 Cr | ₹232.3 Cr | ₹197 Cr | ₹191 Cr | ₹195.6 Cr | ₹200.1 Cr | ₹178.4 Cr | ₹185.6 Cr | ₹163.8 Cr | ₹173.5 Cr |
| Finance Costs | ₹3.7 Cr | ₹6.2 Cr | ₹2.6 Cr | ₹3.9 Cr | ₹7.9 Cr | ₹8.3 Cr | ₹8.5 Cr | ₹8.3 Cr | ₹10.9 Cr | ₹7 Cr | ₹7.8 Cr | ₹4.3 Cr |
| Depreciation & Amortisation | ₹106.7 Cr | ₹105.4 Cr | ₹98 Cr | ₹96.5 Cr | ₹90.2 Cr | ₹99.1 Cr | ₹79.8 Cr | ₹83.4 Cr | ₹79.9 Cr | ₹78.3 Cr | ₹80.3 Cr | ₹69.7 Cr |
| Other Expenses | ₹341.6 Cr | ₹281.4 Cr | ₹310.1 Cr | ₹340 Cr | ₹331.5 Cr | ₹298.8 Cr | ₹325.8 Cr | ₹287.9 Cr | ₹317.4 Cr | ₹277 Cr | ₹270.6 Cr | ₹247.3 Cr |
| Total Expenses | ₹1,338.7 Cr | ₹1,185 Cr | ₹1,431.6 Cr | ₹1,481.8 Cr | ₹1,429.6 Cr | ₹1,496.2 Cr | ₹1,681.1 Cr | ₹1,577.4 Cr | ₹1,390 Cr | ₹1,429.2 Cr | ₹1,653.6 Cr | ₹1,516.6 Cr |
| Profit Before Exceptional Items & Tax | ₹302.1 Cr | ₹257.4 Cr | ₹523.2 Cr | ₹504.6 Cr | ₹430.9 Cr | ₹480.5 Cr | ₹662.1 Cr | ₹564.2 Cr | ₹408.9 Cr | ₹524.4 Cr | ₹510.2 Cr | ₹440.7 Cr |
| Exceptional Items | -₹2 Cr | ₹105.1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹300.1 Cr | ₹362.5 Cr | ₹523.2 Cr | ₹504.6 Cr | ₹430.9 Cr | ₹480.5 Cr | ₹662.1 Cr | ₹564.2 Cr | ₹408.9 Cr | ₹524.4 Cr | ₹510.2 Cr | ₹440.7 Cr |
| Total Tax Expense | ₹100.3 Cr | ₹51.6 Cr | ₹116 Cr | ₹107.4 Cr | ₹101.7 Cr | ₹108 Cr | ₹154.6 Cr | ₹117.5 Cr | ₹41.8 Cr | ₹77.2 Cr | ₹31.7 Cr | ₹62.5 Cr |
| Net Profit | ₹200.2 Cr | ₹311.3 Cr | ₹409.3 Cr | ₹400 Cr | ₹330.5 Cr | ₹372.7 Cr | ₹508.2 Cr | ₹448.8 Cr | ₹369.5 Cr | ₹448.6 Cr | ₹480.5 Cr | ₹382.9 Cr |
| attributable to Owners | ₹159.6 Cr | ₹311.3 Cr | ₹378.3 Cr | ₹443.3 Cr | ₹378.2 Cr | ₹317.8 Cr | ₹499.3 Cr | ₹454.4 Cr | ₹369.5 Cr | ₹448.6 Cr | ₹480.5 Cr | ₹382.9 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹40.6 Cr | ₹7.8 Cr | -₹31 Cr | ₹43.3 Cr | ₹47.7 Cr | -₹54.9 Cr | -₹8.9 Cr | ₹5.6 Cr | ₹1.9 Cr | ₹19.2 Cr | -₹24.6 Cr | ₹28 Cr |
| Total Comprehensive Income | ₹159.6 Cr | ₹319.1 Cr | ₹378.3 Cr | ₹443.3 Cr | ₹378.2 Cr | ₹317.8 Cr | ₹499.3 Cr | ₹454.4 Cr | ₹371.4 Cr | ₹467.8 Cr | ₹455.9 Cr | ₹410.9 Cr |
| EBITDA (computed) | ₹412.5 Cr | ₹369 Cr | ₹623.8 Cr | ₹605 Cr | ₹529 Cr | ₹587.9 Cr | ₹750.4 Cr | ₹655.9 Cr | ₹499.7 Cr | ₹609.7 Cr | ₹598.3 Cr | ₹514.7 Cr |
| Basic EPS | ₹13.20 | ₹20.52 | ₹26.98 | ₹26.37 | ₹21.79 | ₹24.55 | ₹33.51 | ₹29.59 | ₹24.36 | ₹29.59 | ₹31.67 | ₹25.24 |
| Diluted EPS | ₹13.20 | ₹20.52 | ₹26.98 | ₹26.36 | ₹21.78 | ₹24.55 | ₹33.50 | ₹29.59 | ₹24.35 | ₹29.58 | ₹31.66 | ₹25.24 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Agro Chemicals | ₹1,461.2 Cr | ₹332.5 Cr | ₹11,974 Cr | ₹1,811.5 Cr |
| Pharma | ₹104.8 Cr | -₹48.6 Cr | ₹1,470.1 Cr | ₹401.7 Cr |
| Inter segment adjustment | ₹0 | ₹18.6 Cr | ₹0 | ₹0 |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Agro Chemicals | ₹6,416.8 Cr | ₹1,797.5 Cr | - | - |
| Pharma | ₹300.5 Cr | -₹274.4 Cr | - | - |
| Inter segment adjustment | ₹0 | ₹69.9 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹6,182.7 Cr | ₹7,571.2 Cr | ₹7,145.4 Cr | ₹6,270.4 Cr | ₹5,076.9 Cr | ₹4,276.2 Cr | ₹3,306.8 Cr |
| Other Income | ₹307.7 Cr | ₹300.6 Cr | ₹224.3 Cr | ₹158.9 Cr | ₹99.9 Cr | ₹113.3 Cr | ₹47.9 Cr |
| Total Income | ₹6,490.4 Cr | ₹7,871.8 Cr | ₹7,369.7 Cr | ₹6,429.3 Cr | ₹5,176.8 Cr | ₹4,389.5 Cr | ₹3,354.7 Cr |
| Cost of Materials Consumed | ₹2,788.8 Cr | ₹3,219 Cr | ₹3,395.2 Cr | ₹3,355 Cr | ₹2,788.6 Cr | ₹2,305.4 Cr | ₹1,655.1 Cr |
| Purchases of Stock-in-Trade | ₹104.4 Cr | ₹110.5 Cr | ₹212.2 Cr | ₹156.6 Cr | ₹171.9 Cr | ₹182.2 Cr | ₹160 Cr |
| Changes in Inventories | -₹283 Cr | ₹264.4 Cr | -₹24.8 Cr | -₹94.1 Cr | -₹175 Cr | -₹101.1 Cr | -₹2.3 Cr |
| Employee Benefit Expense | ₹623.8 Cr | ₹595.1 Cr | ₹581.8 Cr | ₹489.7 Cr | ₹448 Cr | ₹365.9 Cr | ₹311.3 Cr |
| Finance Costs | ₹7.4 Cr | ₹6.8 Cr | ₹9.2 Cr | ₹35.5 Cr | ₹12.3 Cr | ₹28.1 Cr | ₹18 Cr |
| Depreciation & Amortisation | ₹304.6 Cr | ₹262.6 Cr | ₹246.1 Cr | ₹221.7 Cr | ₹198.4 Cr | ₹160.3 Cr | ₹133.2 Cr |
| Other Expenses | ₹1,013.2 Cr | ₹1,017.7 Cr | ₹955.3 Cr | ₹843.2 Cr | ₹732.1 Cr | ₹538.7 Cr | ₹485 Cr |
| Total Expenses | ₹4,559.2 Cr | ₹5,476.1 Cr | ₹5,375 Cr | ₹5,007.6 Cr | ₹4,176.3 Cr | ₹3,479.5 Cr | ₹2,760.3 Cr |
| Profit Before Exceptional Items & Tax | ₹1,931.2 Cr | ₹2,395.7 Cr | ₹1,994.7 Cr | ₹1,421.7 Cr | ₹1,000.5 Cr | ₹910 Cr | ₹594.4 Cr |
| Exceptional Items | -₹132.3 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹1,798.9 Cr | ₹2,395.7 Cr | ₹1,994.7 Cr | ₹1,421.7 Cr | ₹1,000.5 Cr | ₹910 Cr | ₹594.4 Cr |
| Total Tax Expense | ₹364.1 Cr | ₹529.2 Cr | ₹264 Cr | ₹210.3 Cr | ₹180.8 Cr | ₹191.1 Cr | ₹152.1 Cr |
| Net Profit | ₹1,434.8 Cr | ₹1,866.5 Cr | ₹1,730.7 Cr | ₹1,211.4 Cr | ₹819.7 Cr | ₹718.9 Cr | ₹442.3 Cr |
| Other Comprehensive Income | -₹141.3 Cr | -₹20.9 Cr | ₹28.1 Cr | -₹39.6 Cr | ₹8.7 Cr | ₹69.5 Cr | -₹56 Cr |
| Total Comprehensive Income | ₹1,293.5 Cr | ₹1,845.6 Cr | ₹1,758.8 Cr | ₹1,171.8 Cr | ₹828.4 Cr | ₹788.4 Cr | ₹386.3 Cr |
| EBITDA (computed) | ₹2,243.2 Cr | ₹2,665.1 Cr | ₹2,250 Cr | ₹1,678.9 Cr | ₹1,211.2 Cr | ₹1,098.4 Cr | ₹745.6 Cr |
| Basic EPS | ₹94.57 | ₹123.03 | ₹114.07 | ₹79.84 | ₹54.03 | ₹48.57 | ₹32.04 |
| Diluted EPS | ₹94.56 | ₹123.02 | ₹114.07 | ₹79.84 | ₹54.03 | ₹48.56 | ₹32.02 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹12,969 Cr | ₹11,919 Cr | ₹10,227 Cr | ₹8,335.8 Cr |
| Non-current Assets | ₹6,220 Cr | ₹5,648.1 Cr | ₹4,209.4 Cr | ₹2,925.3 Cr |
| Current Assets | ₹6,748.6 Cr | ₹6,271.3 Cr | ₹6,018 Cr | ₹5,410.5 Cr |
| Property, Plant & Equipment | ₹3,133.2 Cr | ₹2,860.3 Cr | ₹2,538.1 Cr | ₹2,417.4 Cr |
| Inventories | ₹1,050.2 Cr | ₹837.2 Cr | ₹1,166.8 Cr | ₹1,344.7 Cr |
| Trade Receivables | ₹2,054.1 Cr | ₹1,599.2 Cr | ₹791.6 Cr | ₹759.5 Cr |
| Cash & Equivalents | ₹215.8 Cr | ₹457.3 Cr | ₹765.8 Cr | ₹804.7 Cr |
| Equity (Net Worth) | ₹11,369 Cr | ₹10,303 Cr | ₹8,681.2 Cr | ₹7,096.8 Cr |
| Equity Share Capital | ₹15.2 Cr | ₹15.2 Cr | ₹15.2 Cr | ₹15.2 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹1,391.9 Cr | ₹1,483.8 Cr | ₹1,480.8 Cr | ₹1,152.2 Cr |
| Total Liabilities | ₹1,599.5 Cr | ₹1,616.7 Cr | ₹1,546.2 Cr | ₹1,239 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹694.2 Cr | ₹1,478.5 Cr | ₹2,098.8 Cr | ₹1,502.1 Cr | ₹485.4 Cr |
| Investing Cash Flow | -₹679.8 Cr | -₹1,535.8 Cr | -₹1,932.9 Cr | -₹529.4 Cr | -₹104.1 Cr |
| Financing Cash Flow | -₹255.9 Cr | -₹251.2 Cr | -₹204.8 Cr | -₹430.5 Cr | -₹174.6 Cr |
| Capital Expenditure | ₹963.4 Cr | ₹717.9 Cr | ₹478.3 Cr | ₹304.9 Cr | ₹335.8 Cr |
| Free Cash Flow (computed) | -₹269.2 Cr | ₹760.6 Cr | ₹1,620.5 Cr | ₹1,197.2 Cr | ₹149.6 Cr |
| Dividends Paid | ₹227.8 Cr | ₹227.6 Cr | ₹174.4 Cr | ₹113.7 Cr | ₹75.8 Cr |
| Net Change in Cash | -₹241.5 Cr | -₹308.5 Cr | -₹38.9 Cr | ₹542.2 Cr | ₹206.7 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,391.4 Cr | ₹1,269.6 Cr | ₹1,752.6 Cr | ₹1,769.1 Cr | ₹1,648.2 Cr | ₹1,779.8 Cr | ₹2,131.2 Cr | ₹2,012 Cr | ₹1,626.3 Cr | ₹1,721.2 Cr | ₹1,968.7 Cr | ₹1,829.2 Cr |
| Other Income | ₹71.1 Cr | ₹76.3 Cr | ₹80.3 Cr | ₹80 Cr | ₹68.2 Cr | ₹72.8 Cr | ₹90.5 Cr | ₹69.1 Cr | ₹56.1 Cr | ₹65 Cr | ₹56.1 Cr | ₹47.1 Cr |
| Total Income | ₹1,462.5 Cr | ₹1,345.9 Cr | ₹1,832.9 Cr | ₹1,849.1 Cr | ₹1,716.4 Cr | ₹1,852.6 Cr | ₹2,221.7 Cr | ₹2,081.1 Cr | ₹1,682.4 Cr | ₹1,786.2 Cr | ₹2,024.8 Cr | ₹1,876.3 Cr |
| Cost of Materials Consumed | ₹620.2 Cr | ₹623 Cr | ₹839 Cr | ₹706.6 Cr | ₹738.5 Cr | ₹745.9 Cr | ₹917.8 Cr | ₹816.8 Cr | ₹811.7 Cr | ₹793.2 Cr | ₹873.7 Cr | ₹916.6 Cr |
| Purchases of Stock-in-Trade | ₹6.3 Cr | ₹17.8 Cr | ₹51.9 Cr | ₹28.4 Cr | ₹13.7 Cr | ₹33.4 Cr | ₹37.9 Cr | ₹25.5 Cr | ₹34.4 Cr | ₹32.4 Cr | ₹85.3 Cr | ₹60.1 Cr |
| Changes in Inventories | -₹38 Cr | -₹120 Cr | -₹141.8 Cr | ₹16.8 Cr | -₹4.8 Cr | ₹61.1 Cr | ₹83.3 Cr | ₹124.8 Cr | -₹94.7 Cr | -₹38.1 Cr | ₹96.4 Cr | ₹11.6 Cr |
| Employee Benefit Expense | ₹156.7 Cr | ₹152.4 Cr | ₹150 Cr | ₹164.7 Cr | ₹138.9 Cr | ₹143.2 Cr | ₹150.2 Cr | ₹162.8 Cr | ₹145.8 Cr | ₹151.2 Cr | ₹134.6 Cr | ₹150.2 Cr |
| Finance Costs | ₹2 Cr | ₹2.9 Cr | ₹90 Lakh | ₹1.6 Cr | ₹1.6 Cr | ₹2 Cr | ₹1.4 Cr | ₹1.8 Cr | ₹3.8 Cr | ₹2.1 Cr | ₹1.5 Cr | ₹1.8 Cr |
| Depreciation & Amortisation | ₹84.7 Cr | ₹77.5 Cr | ₹71.8 Cr | ₹70.6 Cr | ₹64.7 Cr | ₹67.1 Cr | ₹65.9 Cr | ₹64.9 Cr | ₹62.3 Cr | ₹61.7 Cr | ₹63.1 Cr | ₹59 Cr |
| Other Expenses | ₹261 Cr | ₹226.8 Cr | ₹246.5 Cr | ₹278.9 Cr | ₹258 Cr | ₹251.6 Cr | ₹257.2 Cr | ₹250.9 Cr | ₹276.2 Cr | ₹238.3 Cr | ₹225.3 Cr | ₹215.5 Cr |
| Total Expenses | ₹1,092.9 Cr | ₹980.4 Cr | ₹1,218.3 Cr | ₹1,267.6 Cr | ₹1,210.6 Cr | ₹1,304.3 Cr | ₹1,513.7 Cr | ₹1,447.5 Cr | ₹1,239.5 Cr | ₹1,240.8 Cr | ₹1,479.9 Cr | ₹1,414.8 Cr |
| Profit Before Exceptional Items & Tax | ₹369.6 Cr | ₹365.5 Cr | ₹614.6 Cr | ₹581.5 Cr | ₹505.8 Cr | ₹548.3 Cr | ₹708 Cr | ₹633.6 Cr | ₹442.9 Cr | ₹545.4 Cr | ₹544.9 Cr | ₹461.5 Cr |
| Exceptional Items | -₹111.7 Cr | -₹20.6 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹257.9 Cr | ₹344.9 Cr | ₹614.6 Cr | ₹581.5 Cr | ₹505.8 Cr | ₹548.3 Cr | ₹708 Cr | ₹633.6 Cr | ₹442.9 Cr | ₹545.4 Cr | ₹544.9 Cr | ₹461.5 Cr |
| Total Tax Expense | ₹60.1 Cr | ₹63.3 Cr | ₹123.5 Cr | ₹117.2 Cr | ₹120 Cr | ₹124.5 Cr | ₹149.5 Cr | ₹135.2 Cr | ₹58.5 Cr | ₹58.9 Cr | ₹80.4 Cr | ₹66.2 Cr |
| Net Profit | ₹197.8 Cr | ₹281.6 Cr | ₹491.1 Cr | ₹464.3 Cr | ₹385.8 Cr | ₹423.8 Cr | ₹558.5 Cr | ₹498.4 Cr | ₹384.4 Cr | ₹486.5 Cr | ₹464.5 Cr | ₹395.3 Cr |
| Other Comprehensive Income | -₹83.1 Cr | -₹3.9 Cr | -₹60 Cr | ₹5.7 Cr | ₹33.6 Cr | -₹36.4 Cr | -₹23.4 Cr | ₹5.3 Cr | ₹9 Cr | ₹9 Cr | -₹20.1 Cr | ₹30.2 Cr |
| Total Comprehensive Income | ₹114.7 Cr | ₹277.7 Cr | ₹431.1 Cr | ₹470 Cr | ₹419.4 Cr | ₹387.4 Cr | ₹535.1 Cr | ₹503.7 Cr | ₹393.4 Cr | ₹495.5 Cr | ₹444.4 Cr | ₹425.5 Cr |
| EBITDA (computed) | ₹456.3 Cr | ₹445.9 Cr | ₹687.3 Cr | ₹653.7 Cr | ₹572.1 Cr | ₹617.4 Cr | ₹775.3 Cr | ₹700.3 Cr | ₹509 Cr | ₹609.2 Cr | ₹609.5 Cr | ₹522.3 Cr |
| Basic EPS | ₹13.04 | ₹18.56 | ₹32.36 | ₹30.61 | ₹25.43 | ₹27.93 | ₹36.82 | ₹32.85 | ₹25.34 | ₹32.04 | ₹30.63 | ₹26.06 |
| Diluted EPS | ₹13.03 | ₹18.56 | ₹32.36 | ₹30.60 | ₹25.42 | ₹27.93 | ₹36.82 | ₹32.85 | ₹25.34 | ₹32.04 | ₹30.63 | ₹26.06 |
Shareholding Pattern of Pi Industries Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 46.09%, foreign institutional investors hold 15.87%, domestic institutional investors hold 31.35%, retail and other public shareholders hold 6.69% of Pi Industries Limited. The company had 133,299 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 46.09% | 46.09% | 46.09% | 46.09% | 46.09% | 46.09% |
| Public | 53.90% | 53.90% | 53.90% | 53.90% | 53.90% | 53.90% |
| Employee Trusts | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 46.09% | 46.09% | 46.09% | 46.09% | 46.74% | 46.74% | 51.35% | 51.38% | 51.43% | 51.55% | 51.72% |
| Public | 53.90% | 53.90% | 53.90% | 53.89% | 53.22% | 53.19% | 48.54% | 48.45% | 48.37% | 48.28% | 48.12% |
| Employee Trusts | 0.01% | 0.01% | 0.02% | 0.03% | 0.04% | 0.06% | 0.11% | 0.17% | 0.20% | 0.17% | 0.17% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | +0.00 | -0.65 | +0.00 | -4.61 | -0.03 | -0.05 | -0.12 | -0.17 | - |
Board & Governance of Pi Industries Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Pi Industries Limited has 10 directors - 4 independent and 2 executive. The board is chaired by Narayan Keelveedhi Seshadri.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Narayan Keelveedhi Seshadri | Non-Executive - Non Independent Director · Chairperson | 2022-09-06 | 6 |
| Mayank Singhal | Executive Director · MD | 1998-09-28 | 1 |
| Rajnish Sarna | Executive Director · MD | 2012-11-07 | 1 |
| Arvind Singhal | Non-Executive - Non Independent Director | 2016-10-05 | 1 |
| T.S Balganesh | Non-Executive - Non Independent Director | 2025-09-05 | 1 |
| Lisa J. Brown | Non-Executive - Independent Director | 2020-08-04 | 1 |
| Shobinder Duggal | Non-Executive - Independent Director | 2021-11-12 | 5 |
| Pia Singh | Non-Executive - Independent Director | 2022-08-03 | 2 |
| Rafael Del Rio Donoso | Non-Executive - Non Independent Director | 2024-02-09 | 1 |
| Vegulaparanan Kasi Viswanathan | Non-Executive - Independent Director | 2025-05-19 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | Shobinder Duggal (Chairperson), Narayan Keelveedhi Seshadri, Lisa J. Brown, Pia Singh, Vegulaparanan Kasi Viswanathan |
| Nomination and remuneration committee | Lisa J. Brown (Chairperson), Narayan Keelveedhi Seshadri, Pia Singh, Vegulaparanan Kasi Viswanathan |
| Stakeholders Relationship Committee | T.S Balganesh (Chairperson), Shobinder Duggal, Rajnish Sarna |
| Risk Management Committee | Mayank Singhal (Chairperson), Narayan Keelveedhi Seshadri, Rajnish Sarna, Shobinder Duggal |
| Corporate Social Responsibility Committee | Pia Singh (Chairperson), Mayank Singhal, Rajnish Sarna, Vegulaparanan Kasi Viswanathan |
Group Structure of Pi Industries Limited
Pi Industries Limited has 5 subsidiary companies, 1 joint venture, and 1 associated company. This group structure data is as of FY 2025. The corporate group structure reflects Pi Industries Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Pi Fermachem Private Limited | U24233RJ2020PTC070968 | - |
| Pi Bioferma Private Limited | U24290RJ2020PTC070948 | - |
| Pi Health Sciences Limited | U24290RJ2021PLC076803 | - |
| Pill Finance And Investments Limited | U65990RJ1992PLC055823 | - |
| Pi Life Science Research Limited | U73100DL2004PLC131109 | - |
Showing major subsidiaries. Total: 5.
Charges & Borrowings of Pi Industries Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2007 | State Bank of India | ₹840 Cr | Open |
| 11 Feb 1993 | State Bank of Bikanare and Jaipur | ₹1.5 Lakh | Open |
| 27 Dec 1991 | Pal Hire Purchase Limited | ₹10.32 Lakh | Open |
| 30 Nov 1990 | Citi Bank N.A. | ₹3.19 Lakh | Open |
| 30 Jul 1988 | State Bank of Bikanare and Jaipur | ₹8.75 Lakh | Open |
Total charge records: 76 View all charges
Employees and EPFO Compliance at Pi Industries Limited
Pi Industries Limited has a workforce of 3,499 employees as of Oct 10, 2025.
Employee Count & EPFO Data of Pi Industries Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Pi Industries Limited
GSTIN & GST Filing Data of Pi Industries Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Pi Industries Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Pi Industries Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Pi Industries Limited
MSME Payment Delays by Pi Industries Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Pi Industries Limited
Subsidiaries & Group Companies of Pi Industries Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Pi Industries Limited with ownership details.
MCA Filings & Documents of Pi Industries Limited
MCA Filings & Documents of Pi Industries Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Pi Industries Limited
Recent News on Pi Industries Limited
Frequently Asked Questions about Pi Industries Limited
Pi Industries Limited is an active public limited company in the agriculture sector based in Udaipur, Rajasthan, India. It was incorporated on 31 December 1946 (80+ years old) and is registered under CIN L24211RJ1946PLC000469. Listed on BSE: 523642 and NSE: PIIND. The company has 3,499 employees.
Pi Industries Limited reported revenue of ₹8,322 Cr for FY 2025 (up 6.00% YoY).
The current directors of Pi Industries Limited are:
The primary industry of Pi Industries Limited is agriculture. The company specifically operates in crop protection. The company is currently active in this sector.
Yes. Pi Industries Limited is listed on both BSE (code: 523642) and NSE (symbol: PIIND).
Pi Industries Limited can be reached at the registered office: Udaisagar Road, Udaipur, Rajasthan, India – 313001, or through the website piindustries.com.